KERYX BIOPHARMACEUTICALS INC Income (Loss) from Continuing Operations, Per Basic Share
KERYX BIOPHARMACEUTICALS INC reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.42 per share for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2012-03-02
- KERYX BIOPHARMACEUTICALS INC income (loss) from continuing operations, per basic share for fiscal 2011 was -$0.42.
- KERYX BIOPHARMACEUTICALS INC income (loss) from continuing operations, per basic share for fiscal 2010 was -$0.34, a 261.90% decline from fiscal 2009.
- KERYX BIOPHARMACEUTICALS INC income (loss) from continuing operations, per basic share for fiscal 2009 was $0.21.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|
| 2011-12-31 | -$0.42 10-K · filed 2012-03-02 |
| 2010-12-31 | -$0.34 10-K · filed 2012-03-02 |
| 2009-12-31 | $0.21 10-K · filed 2012-03-02 |